BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 16338758)

  • 1. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures.
    Craveiro LM; Hakkoum D; Weinmann O; Montani L; Stoppini L; Schwab ME
    Eur J Neurosci; 2008 Nov; 28(9):1808-24. PubMed ID: 18973596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Nogo-A in axonal plasticity, regrowth and repair.
    Pernet V; Schwab ME
    Cell Tissue Res; 2012 Jul; 349(1):97-104. PubMed ID: 22588543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo and axon regeneration.
    Schwab ME
    Curr Opin Neurobiol; 2004 Feb; 14(1):118-24. PubMed ID: 15018947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
    Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
    J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1.
    Fouad K; Klusman I; Schwab ME
    Eur J Neurosci; 2004 Nov; 20(9):2479-82. PubMed ID: 15525289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.
    Weinmann O; Schnell L; Ghosh A; Montani L; Wiessner C; Wannier T; Rouiller E; Mir A; Schwab ME
    Mol Cell Neurosci; 2006; 32(1-2):161-73. PubMed ID: 16697217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
    Pot C; Simonen M; Weinmann O; Schnell L; Christ F; Stoeckle S; Berger P; Rülicke T; Suter U; Schwab ME
    J Cell Biol; 2002 Oct; 159(1):29-35. PubMed ID: 12379801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors.
    Fouad K; Dietz V; Schwab ME
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):204-12. PubMed ID: 11690617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nogo limits neural plasticity and recovery from injury.
    Schwab ME; Strittmatter SM
    Curr Opin Neurobiol; 2014 Aug; 27():53-60. PubMed ID: 24632308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nogo-A functions during the development of the central nervous system and in the adult].
    Mingorance A; Soriano-García E; del Rio JA
    Rev Neurol; 2004 Sep 1-15; 39(5):440-6. PubMed ID: 15378458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of axonal regeneration in neurodegenerative disease: focus on Nogo.
    Strittmatter SM
    J Mol Neurosci; 2002; 19(1-2):117-21. PubMed ID: 12212768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Nogo on the go: from animal models to a clinical trial.
    Zörner B; Schwab ME
    Ann N Y Acad Sci; 2010 Jun; 1198 Suppl 1():E22-34. PubMed ID: 20590535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy.
    Lindau NT; Bänninger BJ; Gullo M; Good NA; Bachmann LC; Starkey ML; Schwab ME
    Brain; 2014 Mar; 137(Pt 3):739-56. PubMed ID: 24355710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Nogo-A in neuroregeneration: a review.
    Wang T; Xiong JQ; Ren XB; Sun W
    Brain Res Bull; 2012 Apr; 87(6):499-503. PubMed ID: 22414960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of the myelin-derived nerve growth inhibitor Nogo-A.
    Schweigreiter R
    Neuron Glia Biol; 2008 May; 4(2):83-9. PubMed ID: 19737432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery and brain reorganization after stroke in adult and aged rats.
    Markus TM; Tsai SY; Bollnow MR; Farrer RG; O'Brien TE; Kindler-Baumann DR; Rausch M; Rudin M; Wiessner C; Mir AK; Schwab ME; Kartje GL
    Ann Neurol; 2005 Dec; 58(6):950-3. PubMed ID: 16315284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PTEN and Nogo Codeletion on Corticospinal Axon Sprouting and Regeneration in Mice.
    Geoffroy CG; Lorenzana AO; Kwan JP; Lin K; Ghassemi O; Ma A; Xu N; Creger D; Liu K; He Z; Zheng B
    J Neurosci; 2015 Apr; 35(16):6413-28. PubMed ID: 25904793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.